Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell lines: Am J Cancer Res. 2020; 10(12): 4488-4497

American Journal of Cancer Research 2026 Open access

Read full text
Authors: Alice Iezzi
DOI: 10.62347/kxsn5341
Cited by: 4
References: 40

Abstract

[This corrects the article on p. 4488 in vol. 10, PMID: 33415013.].

Fields of Study & Subjects

PI3K/AKT/mTOR signaling in cancer Cancer-related Molecular Pathways Melanoma and MAPK Pathways

Publication details

Journal / source
American Journal of Cancer Research
Publisher
e-Century Publishing Corporation
Volume
16
Issue
2
Pages
766–768
Publication date
1 January 2026
Language
EN